Article

CMS drops appeal of Stark ruling on lithotripsy

Washington-The Centers for Medicare and Medicaid Services has dropped its appeal of a recent U.S. District Court ruling that lithotripsy should not be encompassed within the Stark II ban on physician self-referrals. With the withdrawal, the court's decision on the matter is final, according to the attorney representing the American Lithotripsy Society (ALS) and Urology Society of America (USA).

Related Videos
Phillip M. Pierorazio, MD, answers a question during a video interview
Michael Jenson, PA-C, answers a question during a Zoom video interview
Prostate cancer cells | Image Credit: © Dr_Microbe - stock.adobe.com
Couple talking with doctor | Image Credit: © Chinnapong - stock.adobe.com
Related Content
Pembro/chemo combo shows promise in small cell/neuroendocrine bladder and prostate cancer
December 2nd 2024

Pembro/chemo combo shows promise in small cell/neuroendocrine bladder and prostate cancer

Hannah Clarke
“The combination of pembrolizumab and chemotherapy presents a promising new treatment approach for these challenging-to-treat, rare cancers and could be a major breakthrough for patient care,” says Arnold I. Chin, MD, PhD.
Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
November 27th 2024

Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD
Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.
Phase 2 trial launches of autologous prostate cancer vaccine
November 27th 2024

Phase 2 trial launches of autologous prostate cancer vaccine

Hannah Clarke
The phase 2 CELLVX-230 trial is exploring the potential of FK-PC101 to delay or prevent prostate cancer recurrence following prostatectomy.
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff
In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.
Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC
November 26th 2024

Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC

Hannah Clarke
“Our study highlights the potential of epigenomic profiling from a simple blood draw to provide a real-time, non-invasive readout of PSMA expression that corresponds with treatment response," says Jacob E. Berchuck, MD.
UGN-101 demonstrates long-term durability in low-grade UTUC
November 26th 2024

UGN-101 demonstrates long-term durability in low-grade UTUC

Hannah Clarke
“The median DOR of 47.8 months in patients who achieved complete response with JELMYTO provides evidence of robust durability in maintaining control of low-grade UTUC over an extended period,” says Phillip Pierorazio, MD.
© 2024 MJH Life Sciences

All rights reserved.